Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation

Clinical Chemistry

Volumn 64, Issue 5, 2018, Pages 820-829

  Greenslade, Jaimi ^a,b   Cho, Elizabeth ^b   Van Hise, Christopher ^b   Hawkins, Tracey ^a   Parsonage, William ^a,b,c   Ungerer, Jacobus ^d   Tate, Jillian ^d   Pretorius, Carel ^d   Than, Martin ^e   Cullen, Louise ^a,b,c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d Pathology Queensland   (Australia)

^e CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL EVALUATION; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN DETERMINATION; BLOOD; HEART INFARCTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TROPONIN I; YOUNG ADULT;

EID: 85046116180     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2017.283887     Document Type: Article

References (36)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020 –35.
2. Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tide-man PA, et al. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ 2016;25: 895–951.
3. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart 2005;91:229 –30.
4. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33: 2252–7.
5. Jaeger C, Wildi K, Twerenbold R, Reichlin T, Rubini Gimenez M, Neuhaus JD, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J 2016;171:92–102.
6. Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de-Filippi C, McCord J, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 2016;68:76 – 87.
7. Reichlin T, Cullen L, Parsonage WA, Greenslade J, Twerenbold R, Moehring B, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med 2015;128:369 –79.e4.
8. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267–315.
9. Neumann J, Sorensen N, Ojeda F, Schwemer T, Lehm-acher J, Gonner S, et al. Immediate rule-out of acute myocardial infarction using electrocardiogram and baseline high-sensitivity troponin I. Clin Chem 2017; 63:394 – 402.
10. Shah ASV, Anand A, Sandoval Y, Lee KK, Smith SW, Ad-amson PD, et al. High sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015;386:2481– 8.
11. Pickering JW, Than M, Cullen L, Aldous S, Avest E, Body R, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med 2017;166:715–24.
12. Rubini Giménez M, Hoeller R, Reichlin T, Zellweger C, Twerenbold R, Reiter M, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013; 168:3896 –901.
13. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011; 58:1332–9.
14. Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, et al. The use of very low concentrations of high-sensitivity troponin T to rule out acute myocardial infarction using a single blood test. Acad Emerg Med 2016;23:1004 –13.
15. Sandoval Y, Smith SW, Love SA, Sexter A, Schulz KM, Apple FS. Single high-sensitivity cardiac troponin I to rule out acute myocardial infarction. Am J Med 2017; 130:1076 – 83.
16. Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA 2017;318:1913–24.
17. Sherwood MW, Kristin Newby L. High-sensitivity troponin assays: evidence, indications, and reasonable use. J Am Heart Assoc 2014;3:e000403.
18. Than M, Cullen L, Aldous S, Parsonage WA, Reid CM, Greenslade J, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 2012;59:2091– 8.
19. Cullen L, Greenslade J, Hawkins T, Hammett C, O’Kane S, Ryan K, et al. IMProved assessment of chest pain trial (IMPACT): an intervention study of a new accelerated protocol for patients with possible acute coronary syndrome. Med J Aust 2017;207:195–200.
20. Luepker RV, Apple FS, Christenson RH, Crow RS, Fort-mann SP, Goff D, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543–9.
21. Cullen L, Than M, Brown AF, Richards M, Parsonage W, Flaws D, et al. Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia. Emerg Med Austra-las 2010;22:35–55.
22. Thygesen K, Alpert J, White H. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50: 2173–95.
23. Carlton EW, Greenslade J, Cullen L, Body R, Than M, Pickering JW, et al. Evaluation of high sensitivity cardiac troponin I levels in patients with suspected acute coronary syndrome. JAMA Cardiol 2016;1:405–12.
24. Pires AM, Amado C. Interval estimators for binomial proportion: comparison of twenty methods. REVSTAT Stat J 2008;6:165–97.
25. Than M, Herbert M, Flaws D, Cullen L, Hess E, Hollander JE, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the emergency department? A clinical survey. Int J Cardiol 2013;166:752– 4.
26. Carlton EW, Kendall J, Khattab A, Greaves K. Low concentrations of high-sensitivity troponin T at presentation to the emergency department. Clin Chem 2017; 63:431–2.
27. Body R, Burrows G, Carley S, Cullen L, Than M, Jaffe A, et al. High-sensitivity cardiac troponin T concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation. Clin Chem 2015;61:983–9.
28. Boeddinghaus JR, Nestelberger TJ, Twerenbold RI, Wildi KI, Badertscher PI, Cupa JI, et al. Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I. Circulation 2017;135:1597– 611.
29. Parsonage W, Mueller C, Greenslade JH, Wildi K, Pickering JW, Than M, et al. Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests. Heart 2016;102: 1279 – 86.
30. Chapman AR, Shah ASV, Mills NL. Comment: appropriate use of high-sensitivity cardiac troponin levels in patients with suspected acute myocardial infarction. JAMA Cardiol 2017;2:228.
31. Altman D, Bland J. Diagnostic tests 2: predictive values. BMJ 1994;309:102.
32. Neumann J, Sorensen N, Schwemer T, Ojeda F, Bourry R, Sciacca V, et al. Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol 2016;1:397– 404.
33. Reichlin T, Twerenbold R, Wildi K, Rubini Gimenez M, Bergsma N, Haaf P, et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ 2015;187:E243–52.
34. Roos A, Bandstein N, Lundback M, Hammarsten O, Ljung R, Holzmann M. Stable high-sensitivity cardiac troponin T levels and long-term mortality in patients with chest pain. J Am Coll Cardiol 2017;70:2226 –36.
35. Thorsteinsdottir I, Aspelund T, Gudmundsson E, Eiriksdottir G, Harris TB, Launer LJ, et al. High-sensitivity cardiac troponin I as a strong predictor of cardiovascular events and mortality in the AGES-Reykjavik community-based cohort of older individuals. Clin Chem 2015;62:623–30.
36. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304: 2503–12.